Results 231 to 240 of about 5,799,531 (403)
Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon Cancer. [PDF]
Turkoglu E +12 more
europepmc +1 more source
Parameters of radical resection in laparoscopic and open colon and rectal cancer surgery
Igor Krdžić +5 more
openalex +2 more sources
Tumor Sidedness Could be a High-risk Factor in Patients with Stage II Colon Cancer [PDF]
Kenta Iguchi +10 more
openalex +1 more source
After the intravenous injection of biomimetic and pH/ROS‐responsive PTSK@CRM, the nanoparticles can be accumulated in tumors and release Sim and KYNase to inhibit the tumor growth, regulate the metabolism of cholesterol and Kyn, and reverse the immunosuppressive tumor microenvironment.
Jiaxin Yin +6 more
wiley +1 more source
FSTL1 is a prognostic marker and promotes invasion and metastasis of colon cancer. [PDF]
Zhong C +8 more
europepmc +1 more source
Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier
SETD2 ablation causes dysregulation and recruitment defects of ribosome biogenesis factors, resulting in translational disorders of barrier maintenance genes, thereby compromising the intestinal barrier. These findings unveil a previously unappreciated role of ribosome biogenesis and translational regulation in preserving the intestinal epithelial ...
Hanyu Rao +11 more
wiley +1 more source
Risk Prediction of Colon Cancer Metastasis and Bioinformatics Analysis of Aspirin Treatment. [PDF]
Li J, Yu X, Shao J, Zhang H, Yu J.
europepmc +1 more source
Fatty acids and colon cancer in experimental models [PDF]
David M. Klurfeld, AW Bull
openalex +1 more source
Metformin Impairs Breast Cancer Growth through the Inhibition of PRMT6
Metformin has a biological activity against breast cancer. However, it is largely unknown about its precise therapeutic targets. Here, histone arginine methyltransferase PRMT6 is identified as a new anti‐cancer target for metformin. Metformin directly binds PRMT6 and inhibits its ability to catalyze histone H3R2 asymmetric dimethylation (H3R2me2a ...
Yinsheng Wu +9 more
wiley +1 more source

